TY - JOUR
T1 - Trypsin activates pancreatic duct epithelial cell ion channels through proteinase-activated receptor-2
AU - Nguyen, Toan D.
AU - Moody, Mark W.
AU - Steinhoff, Martin
AU - Okolo, Charles
AU - Koh, Duk Su
AU - Bunnett, Nigel W.
PY - 1999/1
Y1 - 1999/1
N2 - Proteinase-activated receptor-2 (PAR-2) is a G protein-coupled receptor that is cleaved by trypsin within the NH2-terminus, exposing a tethered ligand that binds and activates the receptor. We examined the secretory effects of trypsin, mediated through PAR-2, on well-differentiated nontransformed dog pancreatic duct epithelial cells (PDEC). Trypsin and activating peptide (AP or SLIGRL-NH2, corresponding to the PAR-2 tethered ligand) stimulated both an 125I- efflux inhibited by Ca2+-activated Cl- channel inhibitors and a 86Rb+ efflux inhibited by a Ca2+-activated K+ channel inhibitor. The reverse peptide (LRGILS-NH2) and inhibited trypsin were inactive. Thrombin had no effect, suggesting absence of PAR-1, PAR-3, or PAR-4. In Ussing chambers, trypsin and AP stimulated a short- circuit current from the basolateral, but not apical, surface of PDEC monolayers. In monolayers permeabilized basolaterally or apically with nystatin, AP activated apical Cl- and basolateral K+ conductances. PAR-2 agonists increased [Ca2+](i) in PDEC, and the calcium chelator BAPTA inhibited the secretory effects of AP. PAR-2 expression on dog pancreatic ducts and PDEC was verified by immunofluorescence. Thus, trypsin interacts with basolateral PAR-2 to increase [Ca2+](i) and activate ion channels in PDEC. In pancreatitis, when trypsinogen is prematurely activated, PAR-2- mediated ductal secretion may promote clearance of toxins and debris.
AB - Proteinase-activated receptor-2 (PAR-2) is a G protein-coupled receptor that is cleaved by trypsin within the NH2-terminus, exposing a tethered ligand that binds and activates the receptor. We examined the secretory effects of trypsin, mediated through PAR-2, on well-differentiated nontransformed dog pancreatic duct epithelial cells (PDEC). Trypsin and activating peptide (AP or SLIGRL-NH2, corresponding to the PAR-2 tethered ligand) stimulated both an 125I- efflux inhibited by Ca2+-activated Cl- channel inhibitors and a 86Rb+ efflux inhibited by a Ca2+-activated K+ channel inhibitor. The reverse peptide (LRGILS-NH2) and inhibited trypsin were inactive. Thrombin had no effect, suggesting absence of PAR-1, PAR-3, or PAR-4. In Ussing chambers, trypsin and AP stimulated a short- circuit current from the basolateral, but not apical, surface of PDEC monolayers. In monolayers permeabilized basolaterally or apically with nystatin, AP activated apical Cl- and basolateral K+ conductances. PAR-2 agonists increased [Ca2+](i) in PDEC, and the calcium chelator BAPTA inhibited the secretory effects of AP. PAR-2 expression on dog pancreatic ducts and PDEC was verified by immunofluorescence. Thus, trypsin interacts with basolateral PAR-2 to increase [Ca2+](i) and activate ion channels in PDEC. In pancreatitis, when trypsinogen is prematurely activated, PAR-2- mediated ductal secretion may promote clearance of toxins and debris.
UR - http://www.scopus.com/inward/record.url?scp=0032896792&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032896792&partnerID=8YFLogxK
U2 - 10.1172/JCI2539
DO - 10.1172/JCI2539
M3 - Article
C2 - 9916138
AN - SCOPUS:0032896792
SN - 0021-9738
VL - 103
SP - 261
EP - 269
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 2
ER -